ERBB2 (Erb-B2 receptor tyrosine kinase 2, also known as HER2) attracts a lot of attention in cancer research (Soltoff et al., 1994; Schulze et al., 2005; Gutierrez and Schiff, 2011). Here, ERBB2 is linked to cancer.